Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             124 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Activation of cyclic AMP/PKA pathway inhibits bladder cancer cell invasion by targeting MAP4-dependent microtubule dynamics Ou, Yanqiu
2014
32 1 p. 47.e21-47.e28
4.69999953E29 p.
artikel
2 Active surveillance for low-risk bladder cancer Tiu, Albert
2014
32 1 p. 33.e7-33.e10
3.29670000001E11 p.
artikel
3 Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: Assessment of adequate renal function and influence on outcome Yafi, Faysal A.
2014
32 1 p. 31.e17-31.e24
3.09999969E25 p.
artikel
4 A manpower calculus: The implications of SUO fellowship expansion on oncologic surgeon case volumes See, William A.
2014
32 1 p. 42.e7-42.e12
4.1999580000001E13 p.
artikel
5 A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma Bianchi, Marco
2014
32 1 p. 46.e1-46.e7
4.59999541E8 p.
artikel
6 A replication study examining association of rs6983267, rs10090154, and rs1447295 common single nucleotide polymorphisms in 8q24 region with prostate cancer in Siberians Oskina, Natalia A.
2014
32 1 p. 37.e7-37.e12
3.6999630000001E13 p.
artikel
7 Association of the Charlson comorbidity index and hypertension with survival in men with metastatic castration-resistant prostate cancer Goyal, Jatinder
2014
32 1 p. 36.e27-36.e34
3.59999964E35 p.
artikel
8 Autophagy proteins in prostate cancer: Relation with anaerobic metabolism and Gleason score 1 1 The study was financially supported by the Tumor and Angiogenesis Research Group. Giatromanolaki, Alexandra
2014
32 1 p. 39.e11-39.e18
3.89999961E19 p.
artikel
9 Blood loss associated with radical cystectomy: A prospective, randomized study comparing Impact LigaSure vs. stapling device Thompson III, Ian M.
2014
32 1 p. 45.e11-45.e15
4.49955E16 p.
artikel
10 Boldine induces cell cycle arrest and apoptosis in T24 human bladder cancer cell line via regulation of ERK, AKT, and GSK-3β Gerhardt, Daniéli
2014
32 1 p. 36.e1-36.e9
3.5999999641E10 p.
artikel
11 Changes in epidemiologic features of testicular germ cell cancer: Age at diagnosis and relative frequency of seminoma are constantly and significantly increasing Ruf, Christian G.
2014
32 1 p. 33.e1-33.e6
3.2999671E7 p.
artikel
12 Cisplatin-based combination chemotherapy in septuagenarians with metastatic urothelial cancer Galsky, Matthew D.
2014
32 1 p. 30.e15-30.e21
2.999997E22 p.
artikel
13 Clinical performance and utility of a DNA methylation urine test for bladder cancer 1 1 This study was funded, in part, by MDxHealth (formerly OncoMethlyome Sciences). Abern, Michael R.
2014
32 1 p. 51.e21-51.e26
5.099949E27 p.
artikel
14 Complications associated with single-dose, perioperative mitomycin-C for patients undergoing bladder tumor resection Filson, Christopher P.
2014
32 1 p. 40.e1-40.e8
3.999999601E9 p.
artikel
15 Cryotherapy and its applications in the management of urologic malignancies: A review of its use in prostate and renal cancers Mohammed, Aza
2014
32 1 p. 39.e19-39.e27
3.899999961E28 p.
artikel
16 Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation 1 1 This work was financially supported by National Natural Science Foundation of China (Nos. 30972982 and 81100483). Ma, Xin
2014
32 1 p. 46.e9-46.e17
4.599999954E18 p.
artikel
17 Disparities in stage at diagnosis among adults with testicular germ cell tumors in the National Cancer Data Base Lerro, Catherine C.
2014
32 1 p. 23.e15-23.e21
2.2999977000000004E22 p.
artikel
18 Distal ureterectomy is a safe surgical option in patients with urothelial carcinoma of the distal ureter Dalpiaz, Orietta
2014
32 1 p. 34.e1-34.e8
3.399999661E9 p.
artikel
19 Does increasing the nodal yield improve outcomes in contemporary patients without nodal metastasis undergoing radical prostatectomy? Kluth, Luis A.
2014
32 1 p. 47.e1-47.e8
4.699999531E9 p.
artikel
20 Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans? Hudson, M'Liss A.
2014
32 1 p. 34.e9-34.e18
3.3999999966E19 p.
artikel
21 Dual inhibition by S6K1 and Elf4E is essential for controlling cellular growth and invasion in bladder cancer Kwon, Jong Kyou
2014
32 1 p. 51.e27-51.e35
5.0999999489999995E36 p.
artikel
22 Editorial Board 2014
32 1 p. ii-
1 p.
artikel
23 Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma Rieken, Malte
2014
32 1 p. 49.e7-49.e14
4.899999510000001E15 p.
artikel
24 Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: A critical analysis of 1,994 patients Mitra, Anirban P.
2014
32 1 p. 52.e1-52.e9
5.1999999481E10 p.
artikel
25 Effect of metformin on prostate cancer outcomes after radical prostatectomy Kaushik, Dharam
2014
32 1 p. 43.e1-43.e7
4.29999571E8 p.
artikel
26 Effect of the time from the presentation of symptoms to medical consultation on primary tumor size and survival in patients with testicular cancer: Shift in the last 2 decades Kobayashi, Kazuhiro
2014
32 1 p. 43.e17-43.e22
4.2999569999999996E23 p.
artikel
27 Effect of the timing of orchiectomy on survival in patients with metastatic germ cell tumors of testis Fedyanin, Mikhail
2014
32 1 p. 32.e27-32.e33
3.1999968E34 p.
artikel
28 Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordance Victorson, David E.
2014
32 1 p. 26.e25-26.e31
2.5999974000000002E32 p.
artikel
29 Evaluation of anatomic and morphologic nomogram to predict malignant and high-grade disease in a cohort of patients with small renal masses Bagrodia, Aditya
2014
32 1 p. 37.e17-37.e23
3.6999963E24 p.
artikel
30 Excellent long-term disease control with modern radiotherapy techniques for stage I testicular seminoma—The Mayo Clinic experience Hallemeier, Christopher L.
2014
32 1 p. 24.e1-24.e6
2.3999761E7 p.
artikel
31 Expression and predictive value of lymph-specific markers in urothelial carcinoma of the bladder Hardenberg, Jost von
2014
32 1 p. 54.e9-54.e17
5.399999946E18 p.
artikel
32 Expression of molecular markers associated with the mammalian target of rapamycin pathway in nonmetastatic renal cell carcinoma: Effect on prognostic outcomes following radical nephrectomy Nishikawa, Masatomo
2014
32 1 p. 49.e15-49.e21
4.8999951E22 p.
artikel
33 FASL polymorphism is associated with response to bacillus Calmette-Guérin immunotherapy in bladder cancer Lima, Luís
2014
32 1 p. 44.e1-44.e7
4.39999561E8 p.
artikel
34 FGFR3 overexpression is prognostic of adverse outcome for muscle-invasive bladder carcinoma treated with adjuvant chemotherapy 1 1 This work was supported by Grant CB-2011-04-01 from Korean Foundation for Cancer Research grant and by a Global Frontier Project Grant (NRF-M1AXA002-2010-0029795) of the National Research Foundation funded by the Ministry of Education, Science and Technology of Korea. Sung, Ji-Youn
2014
32 1 p. 49.e23-49.e31
4.899999951E32 p.
artikel
35 Gene-based urinary biomarkers for bladder cancer: An unfulfilled promise? Sapre, Nikhil
2014
32 1 p. 48.e9-48.e17
4.799999952E18 p.
artikel
36 Genetic polymorphisms in NQO1 and SOD2: Interactions with smoking, schistosoma infection, and bladder cancer risk in Egypt Goerlitz, David
2014
32 1 p. 47.e15-47.e20
4.699953E21 p.
artikel
37 Head-to-head comparison of lymph node density and number of positive lymph nodes in stratifying the outcome of patients with lymph node-positive prostate cancer submitted to radical prostatectomy and extended lymph node dissection Passoni, Niccolò Maria
2014
32 1 p. 29.e21-29.e28
2.89999971E29 p.
artikel
38 High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy Raman, Jay D.
2014
32 1 p. 47.e9-47.e14
4.699953000000001E15 p.
artikel
39 High-resolution transrectal ultrasound: Pilot study of a novel technique for imaging clinically localized prostate cancer Pavlovich, Christian P.
2014
32 1 p. 34.e27-34.e32
3.399966E33 p.
artikel
40 High resolution ultrasound features of prostatic rib metastasis: A prospective feasibility study with implication in the high-risk prostate cancer patient Lee, Kenneth S.
2014
32 1 p. 24.e7-24.e11
2.399760000001E12 p.
artikel
41 Human papillomaviruses in urological malignancies: A critical assessment Tolstov, Yanis
2014
32 1 p. 46.e19-46.e27
4.599999954E28 p.
artikel
42 Hydrostatic pressure enhances mitomycin C induced apoptosis in urothelial carcinoma cells Chen, Shao-Kuan
2014
32 1 p. 26.e17-26.e24
2.5999997399999996E25 p.
artikel
43 Impact of bladder neck involvement on progression in patients with primary non–muscle invasive bladder cancer: A prospective validation study Kobayashi, Shuichiro
2014
32 1 p. 38.e29-38.e36
3.79999962E37 p.
artikel
44 Implications for human papillomavirus in penile cancer Flaherty, Amber
2014
32 1 p. 53.e1-53.e8
5.299999471E9 p.
artikel
45 Incidence and location of lymph node metastases in patients undergoing radical cystectomy for clinical non–muscle invasive bladder cancer: Results from a prospective lymph node mapping study Bruins, Harman M.
2014
32 1 p. 24.e13-24.e19
2.3999976E20 p.
artikel
46 Increased BCL2L12 expression predicts the short-term relapse of patients with TaT1 bladder cancer following transurethral resection of bladder tumors Foutadakis, Spyros
2014
32 1 p. 39.e29-39.e36
3.8999996099999997E37 p.
artikel
47 Inferior vena cava resection and reconstruction: Technical considerations in the surgical management of renal cell carcinoma with tumor thrombus González, Javier
2014
32 1 p. 34.e19-34.e26
3.39999966E27 p.
artikel
48 Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma Pignot, Géraldine
2014
32 1 p. 23.e1-23.e8
2.299999771E9 p.
artikel
49 Information for Authors 2014
32 1 p. 55-
1 p.
artikel
50 Inhibition of presenilins attenuates proliferation and invasion in bladder cancer cells through multiple pathways Gai, Jun-Wei
2014
32 1 p. 36.e19-36.e25
3.5999964000000004E26 p.
artikel
51 In-hospital death and hospital-acquired complications among patients undergoing partial cystectomy for bladder cancer in the United States Kates, Max
2014
32 1 p. 53.e9-53.e14
5.299947000000001E15 p.
artikel
52 iNOS expression and NO production contribute to the direct effects of BCG on urothelial carcinoma cell biology Shah, Gopitkumar
2014
32 1 p. 45.e1-45.e9
4.4999999551E10 p.
artikel
53 Interferon alfa in the treatment paradigm for non–muscle-invasive bladder cancer Lamm, Donald
2014
32 1 p. 35.e21-35.e30
3.4999999965E31 p.
artikel
54 Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer Yafi, Faysal A.
2014
32 1 p. 27.e1-27.e6
2.6999731E7 p.
artikel
55 Is there a relationship between leapfrog volume thresholds and perioperative outcomes after radical cystectomy? Sun, Maxine
2014
32 1 p. 27.e7-27.e13
2.69999730000001E14 p.
artikel
56 Ki-67 is an independent indicator in non–muscle invasive bladder cancer (NMIBC); Combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC Ding, Weihong
2014
32 1 p. 42.e13-42.e19
4.1999958E20 p.
artikel
57 Local tumor destruction in renal cell carcinoma—An inpatient population-based study Trudeau, Vincent
2014
32 1 p. 54.e1-54.e7
5.39999461E8 p.
artikel
58 Long-term mortality in patients with germ cell tumors: Effect of primary cancer site on cause of death Alanee, Shaheen R.
2014
32 1 p. 26.e9-26.e15
2.5999974E16 p.
artikel
59 Lymphovascular invasion in clear cell renal cell carcinoma—Association with disease-free and cancer-specific survival Belsante, Michael
2014
32 1 p. 30.e23-30.e28
2.99997E29 p.
artikel
60 Masthead 2014
32 1 p. i-
1 p.
artikel
61 miR-154 inhibits prostate cancer cell proliferation by targeting CCND2 Zhu, Chen
2014
32 1 p. 31.e9-31.e16
3.09999969E17 p.
artikel
62 Molecular aspects of upper tract urothelial carcinoma Patel, Nilay
2014
32 1 p. 28.e11-28.e20
2.7999999972E21 p.
artikel
63 Multi-institutional analysis of sequential intravesical gemcitabine and mitomycin C chemotherapy for non–muscle invasive bladder cancer Lightfoot, Andrew J.
2014
32 1 p. 35.e15-35.e19
3.4996499999999997E20 p.
artikel
64 Pathological characteristics and prognostic effect of peritumoral capsule penetration in renal cell carcinoma after tumor enucleation Minervini, Andrea
2014
32 1 p. 50.e15-50.e22
4.9999995E23 p.
artikel
65 Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results program Shuch, Brian
2014
32 1 p. 23.e9-23.e13
2.29977000000001E14 p.
artikel
66 Patients with metabolic syndrome and widespread high grade prostatic intraepithelial neoplasia are at a higher risk factor of prostate cancer on re-biopsy: A prospective single cohort study Cicione, Antonio
2014
32 1 p. 28.e27-28.e31
2.79972E32 p.
artikel
67 Performance of multiparametric magnetic resonance imaging in the evaluation and management of clinically low-risk prostate cancer Dianat, Seyed Saeid
2014
32 1 p. 39.e1-39.e10
3.89999999611E11 p.
artikel
68 Persistence of urothelial carcinoma of the bladder risk among former smokers: Results from a contemporary, prospective cohort study Welty, Christopher J.
2014
32 1 p. 25.e21-25.e25
2.49975E26 p.
artikel
69 Pharmacogenomics in bladder cancer Dancik, Garrett M.
2014
32 1 p. 16-22
7 p.
artikel
70 Pharmacogenomics: New paradigms for targeted therapy based on individual response to drugs Ganapathi, Ram N.
2014
32 1 p. 1-4
4 p.
artikel
71 Phase II trial of bevacizumab and satraplatin in docetaxel-pretreated metastatic castrate-resistant prostate cancer Vaishampayan, Ulka N.
2014
32 1 p. 31.e25-31.e33
3.0999999689999996E34 p.
artikel
72 Phase II trial of first-line chemotherapy with gemcitabine, etoposide, and cisplatin for patients with advanced urothelial carcinoma Urakami, Shinji
2014
32 1 p. 35.e1-35.e7
3.49999651E8 p.
artikel
73 Posttreatment prognostic nomogram for patients with metastatic urothelial cancer completing first-line cisplatin-based chemotherapy Galsky, Matthew D.
2014
32 1 p. 48.e1-48.e8
4.799999521E9 p.
artikel
74 Precision medicine for metastatic renal cell carcinoma 1 1 Disclosures: Guru Sonpavde, MD: Research support from Novartis, Pfizer, and speaker or advisory board for Novartis, Pfizer, and GSK. Toni K. Choueiri, MD: Research support from Pfizer. Advisory board: Pfizer, Novartis, Aveo, GSK, Bayer/Onyx, and Genentech. No speakers bureau. Sonpavde, Guru
2014
32 1 p. 5-15
11 p.
artikel
75 Predicting response to bacillus Calmette-Guérin (BCG) in patients with carcinoma in situ of the bladder Nunez-Nateras, Rafael
2014
32 1 p. 45.e23-45.e30
4.49999955E31 p.
artikel
76 Predictive factors of chronic kidney disease stage V after partial nephrectomy in a solitary kidney: a multi-institutional study Verhoest, G.
2014
32 1 p. 28.e21-28.e26
2.799972E27 p.
artikel
77 Preoperative decision making for renal cell carcinoma: Cystic morphology in cross-sectional imaging might predict lower malignant potential Huber, Johannes
2014
32 1 p. 37.e1-37.e6
3.6999631E7 p.
artikel
78 Presence of detrusor muscle in bladder tumor specimens—predictors and effect on outcome as a measure of resection quality Shoshany, Ohad
2014
32 1 p. 40.e17-40.e22
3.99996E23 p.
artikel
79 Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation Cohn, Joshua A.
2014
32 1 p. 41.e23-41.e30
4.09999959E31 p.
artikel
80 Primary spermatic cord tumors: Disease characteristics, prognostic factors, and treatment outcomes Rodríguez, Dayron
2014
32 1 p. 52.e19-52.e25
5.1999948E26 p.
artikel
81 Progression, interobserver agreement, and malignancy rate in complex renal cysts (≥Bosniak category IIF) El-Mokadem, Ismail
2014
32 1 p. 24.e21-24.e27
2.3999975999999997E28 p.
artikel
82 Prostate-specific antigen growth rate constant after first-line cytotoxic chemotherapy in metastatic castration-resistant prostate cancer: A monoinstitutional experience Colloca, Giuseppe
2014
32 1 p. 42.e1-42.e5
4.199581E6 p.
artikel
83 Protein kinase A (PKA) pathway is functionally linked to androgen receptor (AR) in the progression of prostate cancer Sarwar, Martuza
2014
32 1 p. 25.e1-25.e12
2.4999999999751E13 p.
artikel
84 Pseudomonas aeruginosa-mannose–sensitive hemagglutinin inhibits epidermal growth factor receptor signaling pathway activation and induces apoptosis in bladder cancer cells in vitro and in vivo Chang, Lei
2014
32 1 p. 36.e11-36.e18
3.59999964E19 p.
artikel
85 Quantification of peripheral blood CD133 mRNA in identifying metastasis and in predicting recurrence of patients with clear cell renal cell carcinoma Feng, Gang
2014
32 1 p. 44.e9-44.e14
4.399956000000001E15 p.
artikel
86 Reliability of prostate-specific antigen-marker in determining biochemical failure during the first 2 years after external beam radiation therapy and hormone therapy in patients with non-operated prostate cancer Vigna-Taglianti, Riccardo
2014
32 1 p. 30.e1-30.e7
2.99999701E8 p.
artikel
87 Risk of prostate and bladder cancers in patients with spinal cord injury: A population-based cohort study 1 Lee, Wen-Yuan
2014
32 1 p. 51.e1-51.e7
5.09999491E8 p.
artikel
88 Roadmap for the development of the University of North Carolina at Chapel Hill Genitourinary OncoLogy Database—UNC GOLD Gallagher, Sarah A.
2014
32 1 p. 32.e1-32.e9
3.1999999681E10 p.
artikel
89 Robotic-assisted laparoscopic prostatectomy in men with metabolic syndrome Kwon, Young Suk
2014
32 1 p. 40.e9-40.e16
3.9999996E17 p.
artikel
90 Sargramostim (GM-CSF) and lenalidomide in castration-resistant prostate cancer (CRPC): Results from a phase I-II clinical trial Garcia, Jorge A.
2014
32 1 p. 33.e11-33.e17
3.2999967E18 p.
artikel
91 Second-line chemotherapy for advanced bladder cancer: A survey of current UK practice Lamb, Benjamin W.
2014
32 1 p. 52.e11-52.e17
5.1999948E18 p.
artikel
92 Serum levels of 17-β-estradiol are not predictive of prostate cancer diagnosis and aggressiveness: Results from an Italian biopsy cohort De Nunzio, Cosimo
2014
32 1 p. 35.e9-35.e13
3.49965000000001E14 p.
artikel
93 Serum testosterone levels after medical or surgical androgen deprivation: A comprehensive review of the literature Nishiyama, Tsutomu
2014
32 1 p. 38.e17-38.e28
3.799999999962E29 p.
artikel
94 Sex differences in incidence and mortality of bladder and kidney cancers: National estimates from 49 countries Donsky, Heather
2014
32 1 p. 40.e23-40.e31
3.9999999600000004E32 p.
artikel
95 Silencing glucose-regulated protein 78 induced renal cell carcinoma cell line G1 cell-cycle arrest and resistance to conventional chemotherapy Lin, Jui-An
2014
32 1 p. 29.e1-29.e11
2.899999999711E12 p.
artikel
96 Squamous cell carcinogenesis and squamous cell carcinoma of the urinary bladder: A contemporary review with focus on nonbilharzial squamous cell carcinoma Rausch, Steffen
2014
32 1 p. 32.e11-32.e16
3.199968E17 p.
artikel
97 STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score Gomes, Inês M.
2014
32 1 p. 53.e23-53.e29
5.299994700000001E30 p.
artikel
98 Surgical management of the distal ureter during radical nephroureterectomy is an independent predictor of oncological outcomes: Results of a current series and a review of the literature Krabbe, Laura-Maria
2014
32 1 p. 54.e19-54.e26
5.399999459999999E27 p.
artikel
99 Table of Contents 2014
32 1 p. iii-xiii
nvt p.
artikel
100 Temsirolimus improves cytotoxic efficacy of cisplatin and gemcitabine against urinary bladder cancer cell lines Pinto-Leite, Rosário
2014
32 1 p. 41.e11-41.e22
4.099999999959E23 p.
artikel
101 The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level—Can it rule out clinically significant prostate cancer? Abd-Alazeez, Mohamed
2014
32 1 p. 45.e17-45.e22
4.499955E23 p.
artikel
102 The current role and limitations of surrogate endpoints in advanced prostate cancer Gomella, Leonard G.
2014
32 1 p. 28.e1-28.e9
2.7999999721E10 p.
artikel
103 The effect of gender and age on kidney cancer survival: Younger age is an independent prognostic factor in women with renal cell carcinoma Rampersaud, Edward N.
2014
32 1 p. 30.e9-30.e13
2.99970000000001E14 p.
artikel
104 The effect of photochemical internalization of bleomycin in the treatment of urothelial carcinoma of the bladder: An in vitro study Arentsen, Harm C.
2014
32 1 p. 49.e1-49.e6
4.8999511E7 p.
artikel
105 The evolving understanding of microRNA in bladder cancer Guancial, Elizabeth A.
2014
32 1 p. 41.e31-41.e40
4.0999999959E41 p.
artikel
106 The impact of hospital volume, residency, and fellowship training on perioperative outcomes after radical prostatectomy Trinh, Quoc-Dien
2014
32 1 p. 29.e13-29.e20
2.89999971E21 p.
artikel
107 The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: Conditional survival analysis Abdollah, Firas
2014
32 1 p. 43.e9-43.e16
4.29999957E17 p.
artikel
108 The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: A multi-institutional study 1 1 This work was supported in part by Grants-in-Aid for Scientific Research (#24791671 to Tanaka N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. Tanaka, Nobuyuki
2014
32 1 p. 48.e19-48.e26
4.79999952E27 p.
artikel
109 The presence of extracapsular extension is associated with an increased risk of death from prostate cancer after radical prostatectomy for patients with seminal vesicle invasion and negative lymph nodes Mikel Hubanks, J.
2014
32 1 p. 26.e1-26.e7
2.59999741E8 p.
artikel
110 The presence of positive surgical margins in patients with organ-confined prostate cancer results in biochemical recurrence at a similar rate to that in patients with extracapsular extension and PSA≤10ng/ml Eminaga, Okyaz
2014
32 1 p. 32.e17-32.e25
3.199999968E26 p.
artikel
111 The prognostic value of C-reactive protein in renal cell carcinoma: A systematic review and meta-analysis Hu, Qingfeng
2014
32 1 p. 50.e1-50.e8
4.999999501E9 p.
artikel
112 The prognostic value of ribonucleotide reductase small subunit M2 in predicting recurrence for prostate cancers Huang, Yasheng
2014
32 1 p. 51.e9-51.e19
5.09999999949E20 p.
artikel
113 The prostate cancer genome: Perspectives and potential Barbieri, Christopher E.
2014
32 1 p. 53.e15-53.e22
5.29999947E23 p.
artikel
114 Tissue slice grafts of human renal cell carcinoma: An authentic preclinical model with high engraftment rate and metastatic potential Thong, Alan E.
2014
32 1 p. 43.e23-43.e30
4.2999995699999995E31 p.
artikel
115 Treating octogenarians with muscle-invasive bladder cancer: Preoperative opportunities for increasing the benefits of surgical intervention Bassett, Jeffrey C.
2014
32 1 p. 37.e13-37.e16
3.6963E17 p.
artikel
116 Treatment outcomes and morbidity following definitive brachytherapy with or without external beam radiation for the treatment of localized prostate cancer: 20-Year experience at Mount Sinai Medical Center Marshall, Richard A.
2014
32 1 p. 38.e1-38.e7
3.79999621E8 p.
artikel
117 Twist1 and Y-box-binding protein-1 are potential prognostic factors in bladder cancer Song, Yoo Hyun
2014
32 1 p. 31.e1-31.e7
3.09999691E8 p.
artikel
118 Up-regulation of TGM2 with ITGB1 and SDC4 is important in the development and metastasis of renal cell carcinoma Erdem, Merve
2014
32 1 p. 25.e13-25.e20
2.49999975E21 p.
artikel
119 Urinary tract infections in patients with orthotopic neobladder Mano, Roy
2014
32 1 p. 50.e9-50.e14
4.999950000000001E15 p.
artikel
120 Urine microRNAs as potential noninvasive biomarkers in urologic cancers Mlcochova, Hana
2014
32 1 p. 41.e1-41.e9
4.0999999591E10 p.
artikel
121 Use of nephron-sparing surgery among renal cell carcinoma patients with diabetes and hypertension Filson, Christopher P.
2014
32 1 p. 27.e15-27.e21
2.6999973E22 p.
artikel
122 Utility of [11C]choline PET/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: Results from a pathologically validated series Passoni, Niccolò M.
2014
32 1 p. 38.e9-38.e16
3.79999962E17 p.
artikel
123 Validation of copy number variants associated with prostate cancer risk and prognosis Blackburn, August
2014
32 1 p. 44.e15-44.e20
4.399956E21 p.
artikel
124 Variations in CYP isoforms and bladder cancer: A superfamily paradigm Sankhwar, Monica
2014
32 1 p. 28.e33-28.e40
2.79999972E41 p.
artikel
                             124 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland